Autonomix Medical (NASDAQ:AMIX – Get Free Report) and Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations and valuation.
Analyst Ratings
This is a summary of recent recommendations and price targets for Autonomix Medical and Rapid Micro Biosystems, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Autonomix Medical | 0 | 0 | 2 | 0 | 3.00 |
| Rapid Micro Biosystems | 0 | 0 | 1 | 1 | 3.50 |
Autonomix Medical presently has a consensus target price of $16.50, suggesting a potential upside of 1,533.66%. Rapid Micro Biosystems has a consensus target price of $8.00, suggesting a potential upside of 198.51%. Given Autonomix Medical’s higher possible upside, equities research analysts plainly believe Autonomix Medical is more favorable than Rapid Micro Biosystems.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Autonomix Medical | N/A | N/A | -$11.41 million | ($5.74) | -0.18 |
| Rapid Micro Biosystems | $28.05 million | 4.19 | -$46.89 million | ($1.01) | -2.65 |
Autonomix Medical has higher earnings, but lower revenue than Rapid Micro Biosystems. Rapid Micro Biosystems is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Autonomix Medical and Rapid Micro Biosystems’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Autonomix Medical | N/A | -172.93% | -133.39% |
| Rapid Micro Biosystems | -145.63% | -63.07% | -48.33% |
Volatility & Risk
Autonomix Medical has a beta of -2.96, indicating that its share price is 396% less volatile than the S&P 500. Comparatively, Rapid Micro Biosystems has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500.
Insider and Institutional Ownership
10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 52.6% of Rapid Micro Biosystems shares are held by institutional investors. 32.4% of Autonomix Medical shares are held by insiders. Comparatively, 30.0% of Rapid Micro Biosystems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Rapid Micro Biosystems beats Autonomix Medical on 8 of the 14 factors compared between the two stocks.
About Autonomix Medical
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
About Rapid Micro Biosystems
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
